top of page
POLTER
OPTIMIZATION OF BALIXAFORTIDE WITH NAB-PACLITAXEL OR ERIBULIN FOR HER2- ADVANCED BREAST CANCER
CLINICAL TRIAL DETAILS
OPTIMIZATION OF BALIXAFORTIDE WITH NAB-PACLITAXEL OR ERIBULIN FOR HER2- ADVANCED BREAST CANCER (POL6326 (BALIXAFORTIDE) PLUS NAB-PACLITAXEL OR ERIBULIN IN PATIENTS WITH HER2-NEGATIVE ADVANCED BREAST CANCER).
-
COUNTRY
STATUS
TUMOR TYPE
PHASE
N
SITES
BREAST
-
I, II
Spain
DRAFT
PRESS RELEASE
-
SCIENTIFIC IMPACT
-
BLOG ARTICLES RELATED
-
TRIAL SITES
-
bottom of page